Oxford BioDynamics Plc
OBD.L · LSE
9/30/2025 | 3/31/2025 | 9/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Revenue | £1 | £1 | £0 | £0 |
| % Growth | -13.5% | 90% | -5.5% | – |
| Cost of Goods Sold | £4 | £4 | £4 | £4 |
| Gross Profit | -£3 | -£3 | -£3 | -£4 |
| % Margin | -604.7% | -524.2% | -1,073.1% | -1,183.5% |
| R&D Expenses | £0 | £0 | £0 | £0 |
| G&A Expenses | £0 | £0 | £0 | £0 |
| SG&A Expenses | £1 | £2 | £2 | £2 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | £0 | £0 | £8 | £0 |
| Operating Expenses | £2 | £3 | £11 | £3 |
| Operating Income | -£5 | -£6 | -£6 | -£6 |
| % Margin | -936.6% | -1,006% | -1,967.3% | -1,955.7% |
| Other Income/Exp. Net | -£1 | £0 | -£1 | £2 |
| Pre-Tax Income | -£6 | -£6 | -£7 | -£5 |
| Tax Expense | -£0 | -£0 | -£0 | -£0 |
| Net Income | -£5 | -£6 | -£7 | -£5 |
| % Margin | -1,063.4% | -979.7% | -2,214.2% | -1,445% |
| EPS | -0.003 | -0.007 | -0.022 | -0.023 |
| % Growth | 58.8% | 68.9% | 6.4% | – |
| EPS Diluted | -0.003 | -0.007 | -0.022 | -0.023 |
| Weighted Avg Shares Out | 0 | 851 | 312 | 202 |
| Weighted Avg Shares Out Dil | 0 | 851 | 312 | 202 |
| Supplemental Information | – | – | – | – |
| Interest Income | -£0 | £0 | £0 | £0 |
| Interest Expense | £0 | £0 | £0 | £0 |
| Depreciation & Amortization | £1 | £1 | £1 | £1 |
| EBITDA | -£5 | -£5 | -£6 | -£4 |
| % Margin | -936.4% | -859.3% | -1,920.7% | -1,232.4% |